tv.qiagenbioinformatics.com marketingbiox@qiagen.com https://tv.qiagenbioinformatics.com Watch tutorials, interviews and much more on our web based TV channel! en-us Visualplatform http://blogs.law.harvard.edu/tech/rss tv.qiagenbioinformatics.com CLC bio TV Watch tutorials, interviews and much more on our web based TV channel! clc bio tv, bioinformatics, genomics, research episodic no https://tv.qiagenbioinformatics.com/files/rv0.0/sitelogo.gif https://tv.qiagenbioinformatics.com http://tv.qiagenbioinformatics.com/photo/117848531/deliver-clinical-molecular-insights <p><p>Cancer care has been transformed by comprehensive molecular profiling and targeted therapies&nbsp;– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.</p><p>That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:</p><ul><li><p>Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.</p></li><li><p>Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.</p></li><li><p>Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time.</p></li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/117848531/deliver-clinical-molecular-insights"><img src="http://tv.qiagenbioinformatics.com/64968576/117848531/329b5bafc47160923a30b713e075904a/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/117848531 Tue, 28 Oct 2025 14:27:49 GMT Deliver Clinical Molecular Insights at Scale with QCI Precision Insights Cancer care has been transformed by comprehensive molecular profiling and targeted therapies– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time. Cancer care has been transformed by comprehensive molecular profiling and targeted therapies– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from... tv.qiagenbioinformatics.com 51:33 <p><p>Cancer care has been transformed by comprehensive molecular profiling and targeted therapies&nbsp;– but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.</p><p>That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:</p><ul><li><p>Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.</p></li><li><p>Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.</p></li><li><p>Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time.</p></li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/117848531/deliver-clinical-molecular-insights"><img src="http://tv.qiagenbioinformatics.com/64968576/117848531/329b5bafc47160923a30b713e075904a/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> qci http://tv.qiagenbioinformatics.com/photo/72567126/get-expert-variant-classification <p>As next-generation DNA sequencing technology continues to evolve and become further integrated into routine clinical testing, the need for efficient and accurate clinical interpretation of oncology diagnostic tests becomes even more pressing—especially among community hospital labs. <p>Standard sequencing panels are growing, drugs are covering more targets and pathways, and the expansion of the scientific and clinical literature has become exponential, presenting a significant challenge to laboratory directors and clinicians who need to understand the implications of the test results. Further, the implications of mutations can be applicable across many cancer types, but often are different based on the specific cancer type.</p> <p>In this webinar, we will discuss how community hospital labs can perform comprehensive genomic profiling faster and with greater accuracy and confidence using QIAGEN’s professional clinical interpretation services: QCI Precision Insights.</p> <p>Attendees will learn:</p> <p>About the world-class team of molecular biologists and oncologists that power QCI Precision Insights<br> How community hospital labs can get up-to-date and detailed disease-specific clinical insights and therapeutic options for each patient within minutes<br> About use-cases and examples of clinical annotation in different diseases of varying specificity</p> <p>Speakers<br> Sheryl Elkin, PhD<br> Chief Scientific Officer<br> N-of-One, a QIAGEN company</p> <p>Linda Call, Ph.D.<br> Director of Scientific and Clinical Operations<br> QIAGEN Digital Insights</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/72567126/get-expert-variant-classification"><img src="http://tv.qiagenbioinformatics.com/64968571/72567126/bcdd05bddbfa47dd5bd3f8db48245d43/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/72567126 Thu, 09 Dec 2021 07:22:05 GMT Get expert variant classification services tailored to your onco-panel As next-generation DNA sequencing technology continues to evolve and become further integrated into routine clinical testing, the need for efficient and accurate clinical interpretation of oncology diagnostic tests becomes even more pressing—especially among community hospital labs. Standard sequencing panels are growing, drugs are covering more targets and pathways, and the expansion of the scientific and clinical literature has become exponential, presenting a significant challenge to laboratory directors and clinicians who need to understand the implications of the test results. Further, the implications of mutations can be applicable across many cancer types, but often are different based on the specific cancer type. In this webinar, we will discuss how community hospital labs can perform comprehensive genomic profiling faster and with greater accuracy and confidence using QIAGEN’s professional clinical interpretation services: QCI Precision Insights. Attendees will learn: About the world-class team of molecular biologists and oncologists that power QCI Precision Insights How community hospital labs can get up-to-date and detailed disease-specific clinical insights and therapeutic options for each patient within minutes About use-cases and examples of clinical annotation in different diseases of varying specificity Speakers Sheryl Elkin, PhD Chief Scientific Officer N-of-One, a QIAGEN company Linda Call, Ph.D. Director of Scientific and Clinical Operations QIAGEN Digital Insights As next-generation DNA sequencing technology continues to evolve and become further integrated into routine clinical testing, the need for efficient and accurate clinical interpretation of oncology diagnostic tests becomes even more... tv.qiagenbioinformatics.com 45:35 <p>As next-generation DNA sequencing technology continues to evolve and become further integrated into routine clinical testing, the need for efficient and accurate clinical interpretation of oncology diagnostic tests becomes even more pressing—especially among community hospital labs. <p>Standard sequencing panels are growing, drugs are covering more targets and pathways, and the expansion of the scientific and clinical literature has become exponential, presenting a significant challenge to laboratory directors and clinicians who need to understand the implications of the test results. Further, the implications of mutations can be applicable across many cancer types, but often are different based on the specific cancer type.</p> <p>In this webinar, we will discuss how community hospital labs can perform comprehensive genomic profiling faster and with greater accuracy and confidence using QIAGEN’s professional clinical interpretation services: QCI Precision Insights.</p> <p>Attendees will learn:</p> <p>About the world-class team of molecular biologists and oncologists that power QCI Precision Insights<br> How community hospital labs can get up-to-date and detailed disease-specific clinical insights and therapeutic options for each patient within minutes<br> About use-cases and examples of clinical annotation in different diseases of varying specificity</p> <p>Speakers<br> Sheryl Elkin, PhD<br> Chief Scientific Officer<br> N-of-One, a QIAGEN company</p> <p>Linda Call, Ph.D.<br> Director of Scientific and Clinical Operations<br> QIAGEN Digital Insights</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/72567126/get-expert-variant-classification"><img src="http://tv.qiagenbioinformatics.com/64968571/72567126/bcdd05bddbfa47dd5bd3f8db48245d43/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> clinical qci precision insights webinar